Contact: Georgina FitzGerald; Last date for abstract submission: Not available; 2nd CKD3 Summit focuses exclusively on overcoming challenges limiting the development of more efficacious & disease-modifying drugs against diabetic nephropathy, genetic & glomerular kidney disease.